Zura Bio Ltd SEC filings ZURA
Zura Bio Ltd has 446 filings in SEC EDGAR's recent list, going back to Apr 8, 2021. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 27, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3 | Shelf registration | Oct 27, 2026 | — |
| S-8 | Employee stock plan registration | Sep 30, 2026 | — |
| 424B5 | Prospectus supplement | Feb 25, 2026 | — |
| 424B5 | Prospectus supplement | Feb 24, 2026 | — |
| S-3/A | Form s-3/a | Sep 16, 2024 | — |
| S-3/A | Form s-3/a | Sep 11, 2024 | — |
| POS AM | Filing | Sep 5, 2024 | — |
| POS AM | Filing | Sep 5, 2024 | — |
| S-3 | Shelf registration | Sep 3, 2024 | — |
| 424B3 | Prospectus | Aug 13, 2024 | — |
| 424B3 | Prospectus | Aug 8, 2024 | — |
| S-4/A | Filing | Jul 25, 2024 | — |
| S-4 | Registration for a merger or exchange | Jul 12, 2024 | — |
| POS AM | Filing | Jun 18, 2024 | — |
| 424B3 | Prospectus | Jun 4, 2024 | — |
| 424B7 | Form 424b7 | May 31, 2024 | — |
| S-1 | Registration statement | May 24, 2024 | — |
| 424B7 | Filing | Oct 16, 2023 | — |
| 424B3 | Prospectus | Sep 14, 2023 | — |
| S-1/A | Amended registration statement | Sep 11, 2023 | — |
| S-1/A | Amended registration statement | Aug 25, 2023 | — |
| S-1/A | Amended registration statement | Aug 11, 2023 | — |
| S-1/A | Amended registration statement | Jul 21, 2023 | — |
| S-8 | Employee stock plan registration | Jun 22, 2023 | — |
| S-1 | Registration statement | Jun 14, 2023 | — |
| 424B3 | Prospectus | Mar 1, 2023 | — |
| S-4/A | Filing | Feb 23, 2023 | — |
| S-4/A | Filing | Feb 17, 2023 | — |
| S-4/A | Filing | Feb 8, 2023 | — |
| S-4/A | Filing | Feb 2, 2023 | — |
| S-4/A | Filing | Jan 9, 2023 | — |
| S-4/A | Form s-4/a | Dec 15, 2022 | — |
| S-4/A | Filing | Oct 25, 2022 | — |
| S-4/A | Filing | Sep 21, 2022 | — |
| S-4 | Registration for a merger or exchange | Aug 22, 2022 | — |
| 424B4 | Prospectus | Jul 14, 2021 | — |
| S-1/A | Amended registration statement | Jul 6, 2021 | — |
| S-1 | Registration statement | Jun 15, 2021 | — |
Showing 38 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ZURA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- La Jolla, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1855644
- Former names
- JATT Acquisition Corp (until Mar 21, 2023)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.